GMILogo_Vertical-Gradient.png
Acne Medication Market worth USD 17.5 Billion by 2032, Says Global Market Insights Inc.
November 28, 2022 05:10 ET | Global Market Insights Inc.
Selbyville, Delaware, Nov. 28, 2022 (GLOBE NEWSWIRE) -- The acne medication market value is set to surpass USD 17.5 billion by 2032, according to a new research report by Global Market Insights...
Derm-Biome-Pharmaceuticals.png
Derm-Biome Pharmaceuticals, Inc. reports positive preclinical data in melanoma and squamous cell carcinoma, initiates a program aimed at advancing topical therapies for skin cancer to the clinic
October 12, 2022 10:00 ET | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on skin health and healthy aging, has...
researchdrivelogo.jpg
Global Radiodermatitis Market Anticipated to Generate a Revenue of $561.7 Million and Rise at a CAGR of 4.1% during the Forecast Timeframe 2021-2028 | Approved [169-Pages] by Research Dive
August 29, 2022 09:08 ET | Research Dive
New York, USA, Aug. 29, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global radiodermatitis market is envisioned to garner a revenue of $561.7 million and grow at a...
GMILogo_Vertical-Gradient.png
U.S. Compounding Pharmacies Market to hit USD 8.7 Billion by 2030, says Global Market Insights Inc.
July 07, 2022 06:15 ET | Global Market Insights Inc.
Selbyville, Delaware, July 07, 2022 (GLOBE NEWSWIRE) -- U.S. compounding pharmacies market value is set to reach USD 8.7 billion by 2030, according to a new research report by Global Market...
Jerry Grisaffi, CEO of Right on Brands, Discusses New Products, 2021 Milestones and 2022 Goals in Audio Interview with SmallCapVoice.com
December 08, 2021 08:00 ET | Right On Brands, Inc.
AUSTIN, Texas, Dec. 08, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Right on Brands, Inc. (OTC PINK: RTON), a fully reporting SEC filer...
researchdrivelogo.jpg
Global Lyme Disease Treatment Market Projected to Surpass $1,062,794.78 Thousand, Growing at 7.50% CAGR from 2021 to 2028 – Exclusive Report [180 Pages] By Research Dive
November 15, 2021 09:00 ET | Research Dive
New York, USA, Nov. 15, 2021 (GLOBE NEWSWIRE) -- A new report on the global lyme disease treatment market has been added by Research Dive to its repository. As per the report, the market is expected...
researchdrivelogo.jpg
Global Radiodermatitis Market Expected to Garner a Revenue of $561.7 Million by 2028, Growing at a CAGR of 4.1% from 2021-2028 – Exclusive Report [169 Pages] By Research Dive
November 08, 2021 09:00 ET | Research Dive
New York, USA, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Research Dive has added a new report to its offering titled, “Radiodermatitis Market by Product (Topical, Oral, and Dressings), Distribution Channel...
Derm-Biome-Pharmaceuticals.png
Derm-Biome Pharmaceuticals, Inc. reports Positive Results from a Preclinical Study in Atopic Dermatitis: its new generation of compounds are significantly more effective than FDA-approved topical AD drug crisaborole
September 16, 2021 10:00 ET | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is pleased to...
grapefruit LOGO.png
Captor Capital’s California Retail Cannabis Dispensaries to Carry Grapefruit’s Patented Hourglass THC/CBD Delivery Cream
July 06, 2021 06:00 ET | Grapefruit USA Inc.
LOS ANGELES, July 06, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), a premiere California-based cannabis and hemp company, is...
Derm-Biome-Pharmaceuticals.png
Derm-Biome Pharmaceuticals, Inc. files a US provisional patent for a new generation of natural product-based derivatives and their uses for treating chronic inflammatory skin conditions
June 29, 2021 09:30 ET | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, June 29, 2021 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a private Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is...